A new study warns that patients who have suffered recent strokes may face a higher risk of retaining potentially toxic gadolinium deposits in the brain after receiving MRI contrast dyes,…
A federal judge has dismissed plaintiff experts who were key to proving that gadolinium deposition can cause a host of health problems.
A new study finds that older, linear gadolinium contrast agents appear to have a much higher risk of leaving behind high levels of gadolinium in the brain.
A lawsuit against Bayer accuses the manufacturer's Magnevist MRI contrast dye of causing gadolinium deposition disease.
A Magnevist lawsuit claims the MRI contrast dye caused deposits of gadolinium to build up in the plaintiff's organs and soft tissues.
A gadolinium exposure lawsuit claims that IV injections of various MRI contrast dyes caused severe injury due to an allergic reaction.
Changes in children's brains may make them more susceptible to gadolinium retention after the age of two, according to the findings of a new study.
A gadolinium retention lawsuit says Multihance, Magnevist and Omniscan MRI contrast dyes are defective, resulting in injury from toxic chemicals.
A new study indicates that linear gadolinium contrast dyes leave deposits of the chemical in rat brains for at least a year.
Growing evidence suggests some types of MRI contrast dyes may be more prone to leave behind traces of gadolinium in the human body.